Nu Skin Enterprises is at a potential inflection point with seemingly stabilized revenue. Management's restructuring and innovative product focus, particularly through the Rhyz business, show promi...

Nu Skin is encountering persistent macroeconomic obstacles, weighing on consumer spending and customer acquisition.

Nu Skin encounters macroeconomic challenges related to volatile consumer spending and strong currency headwinds.

Nu Skin (NUS) has been battling persistent macroeconomic headwinds, which have been weighing on consumer spending and customer acquisition. Strong currency headwinds are also playing foul.

The cosmetics purveyor released its latest set of quarterly results. It beat on both revenue and profitability, but investors were more concerned about the future.

Nu Skin's (NUS) Q2 results are likely to reflect the impacts of macroeconomic challenges, including inflation and adverse currency fluctuations.

Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.37 per share a year ago.

Nu Skin's (NUS) first-quarter 2024 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations are a concern.

Nu Skin delivered a better-than-feared quarter to end 2023. The personal care products company is grappling with macro headwinds amid an ongoing restructuring plan.

Nu Skin's (NUS) fourth-quarter 2023 results reflect the persistence of macroeconomic challenges and hurdles related to business transformation, offset by growth in some regions.

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.89 per share a year ago.

Nu Skin's (NUS) fourth-quarter 2023 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations pose concerns.

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin (NUS) is benefiting from the Nu Vision 2025 strategy driven by a dynamic affiliate opportunity platform. However, escalating macroeconomic pressures are hampering key markets.